Topic of the day: Brexit
I don't think I have anything intelligent to add to the discussion, not being a subject of the UK, nor a citizen of the EU. Thanks to C&EN's Alex Scott and his article on potential Brexit impacts (written before the referendum), I learned that the European Medicines Agency is in London
For the U.K. pharmaceutical industry, a Brexit risks causing uncertainty and creating barriers to investment. “It’s vital the U.K. remains engaged in the EU to influence legislative and regulatory policy developments affecting the life sciences ecosystem,” says the BioIndustry Association, a U.K. industry organization. Ninety life sciences firms have stated publicly that the U.K. should stay in the EU.
Additionally, if the U.K. votes to Brexit, two European pharmaceutical institutions currently based in London—the European Medicines Agency and a part of the EU’s planned unitary patent system—would have to relocate to an EU country.I believe the EMA is basically the EU's version of the FDA. The German pharma sector calling for them to leave (and relocate to Berlin?) already.
I was also surprised to learn that good ol' Paul Hodges (Captain of the DOOOOOOOOOOOOOOOOOOM team) was actually voting Remain. Huh.
I presume there are a raft of people who have Marie Curie Fellowships and the like, who may face some trouble? Readers, your thoughts?
Topic of the day: Brexit
Reviewed by Cakrawala News
on
8:22 AM
Rating:
No comments: